Braidwell LP: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1920938) · Explore on the interactive board
Braidwell LP disclosed 86 US equity positions worth $2.7bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is CAI at 5.4% of the reported book, followed by HNGE, GKOS. The top ten holdings are 31.6% of the book, and the portfolio behaves like about 51 equal-weight positions. Versus the prior filing it opened 24 new positions, added to 21, reduced 35 and exited 25. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Braidwell LP own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 24 new, 21 added, 35 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | CAI CARIS LIFE SCIENCES INC | Healthcare | 5.4% | $147.1m | 8,256,032 | 3% | added |
| 2 | HNGE HINGE HEALTH INC | Healthcare | 4.1% | $110.4m | 1,330,127 | -9% | reduced |
| 3 | GKOS GLAUKOS CORP | Healthcare | 3.1% | $82.7m | 591,927 | -22% | reduced |
| 4 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 3.0% | $81.1m | 1,996,965 | -15% | reduced |
| 5 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 2.9% | $78.1m | 879,467 | -6% | reduced |
| 6 | IRTC IRHYTHM HOLDINGS INC | Healthcare | 2.9% | $77.8m | 654,262 | 7% | added |
| 7 | NEO NEOGENOMICS INC | Healthcare | 2.7% | $71.8m | 4,918,202 | -12% | reduced |
| 8 | KOD KODIAK SCIENCES INC | Healthcare | 2.6% | $69.6m | 1,787,318 | -2% | reduced |
| 9 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.5% | $68.3m | 1,131,452 | -15% | reduced |
| 10 | ALPHATEC HLDGS INC | 2.4% | $66.2m | 69,121,000 | 12% | added | |
| 11 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 2.2% | $59.3m | 2,451,562 | -24% | reduced |
| 12 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 2.1% | $58.0m | 594,562 | -34% | reduced |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.1% | $56.7m | 336,171 | -48% | reduced |
| 14 | ATEC ALPHATEC HLDGS INC | Healthcare | 2.1% | $56.5m | 6,531,439 | 201% | added |
| 15 | GENB GENERATE BIOMEDICINES INC | 2.0% | $55.4m | 3,283,844 | -9% | reduced | |
| 16 | MRVI MARAVAI LIFESCIENCES HLDGS I | Healthcare | 2.0% | $54.3m | 8,702,921 | -15% | reduced |
| 17 | KRYS KRYSTAL BIOTECH INC | Healthcare | 1.8% | $47.9m | 128,975 | -29% | reduced |
| 18 | HUM HUMANA INC | Healthcare | 1.7% | $45.5m | 114,500 | – | new |
| 19 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 1.7% | $44.8m | 89,395 | -4% | reduced |
| 20 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 1.6% | $43.4m | 378,163 | 12% | added |
| 21 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.6% | $42.3m | 381,128 | 23% | added |
| 22 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 1.6% | $42.1m | 1,620,377 | 81% | added |
| 23 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 1.5% | $41.7m | 1,646,399 | -33% | reduced |
| 24 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 1.5% | $41.6m | 596,753 | -41% | reduced |
| 25 | TMDX TRANSMEDICS GROUP INC | Healthcare | 1.5% | $40.5m | 609,715 | 85% | added |
| 26 | MBX MBX BIOSCIENCES INC | Healthcare | 1.5% | $39.2m | 710,880 | -52% | reduced |
| 27 | CLYM CLIMB BIO INC | Healthcare | 1.3% | $36.5m | 2,797,375 | 83% | added |
| 28 | CDNA CAREDX INC | Healthcare | 1.3% | $34.8m | 1,220,602 | -44% | reduced |
| 29 | MAZE MAZE THERAPEUTICS INC | Healthcare | 1.3% | $34.0m | 1,140,040 | – | new |
| 30 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 1.3% | $34.0m | 483,822 | -10% | reduced |
| 31 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 1.2% | $33.7m | 1,141,477 | 77% | added |
| 32 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.2% | $33.1m | 473,617 | 113% | added |
| 33 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 1.2% | $31.8m | 2,126,298 | 21% | added |
| 34 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.2% | $31.2m | 1,286,769 | -27% | reduced |
| 35 | INSP INSPIRE MED SYS INC | Healthcare | 1.1% | $30.2m | 677,570 | 0% | held |
| 36 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.1% | $30.1m | 1,629,182 | – | new |
| 37 | ALMR ALAMAR BIOSCIENCES INC | 1.1% | $29.4m | 1,083,983 | – | new | |
| 38 | DHR DANAHER CORP DEL | Healthcare | 1.1% | $28.7m | 150,627 | 8% | added |
| 39 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.0% | $27.9m | 70,137 | -9% | reduced |
| 40 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.0% | $26.5m | 278,164 | – | new |
| 41 | AVALYN PHARMACEUTICALS INC | 1.0% | $26.4m | 801,395 | – | new | |
| 42 | AVAH AVEANNA HEALTHCARE HLDGS INC | Healthcare | 1.0% | $26.3m | 3,065,106 | 39% | added |
| 43 | BIOA BIOAGE LABS INC | 0.9% | $25.3m | 1,033,129 | -14% | reduced | |
| 44 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.9% | $25.1m | 587,567 | 70% | added |
| 45 | VERA VERA THERAPEUTICS INC | Healthcare | 0.9% | $24.2m | 564,724 | 8% | added |
| 46 | RGEN REPLIGEN CORP | Healthcare | 0.9% | $24.2m | 177,100 | 273% | added |
| 47 | ZURA ZURA BIO LTD | Healthcare | 0.9% | $23.5m | 3,980,295 | -0% | held |
| 48 | GH GUARDANT HEALTH INC | Healthcare | 0.8% | $22.2m | 147,850 | -70% | reduced |
| 49 | EOLS EVOLUS INC | Healthcare | 0.8% | $21.9m | 3,155,209 | 2% | added |
| 50 | NTRA NATERA INC | Healthcare | 0.8% | $21.6m | 79,500 | -38% | reduced |
What did Braidwell LP sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| GH GUARDANT HEALTH INC | 15.2% | $102.6m |
| CNTA CENTESSA PHARMACEUTICALS PLC | 11.7% | $78.9m |
| NUVALENT INC | 10.6% | $71.8m |
| CGON CG ONCOLOGY INC | 9.9% | $66.7m |
| APGE APOGEE THERAPEUTICS INC | 6.0% | $40.3m |
| PEN PENUMBRA INC | 5.1% | $34.6m |
| SLNOEUR SOLENO THERAPEUTICS INC | 4.7% | $32.1m |
| ILMN ILLUMINA INC | 4.2% | $28.3m |
| BMRN BIOMARIN PHARMACEUTICAL INC | 4.2% | $28.1m |
| ESTA ESTABLISHMENT LABS HLDGS INC | 3.9% | $26.3m |
| FULC FULCRUM THERAPEUTICS INC | 3.6% | $24.0m |
| CVS CVS HEALTH CORP | 3.1% | $20.9m |
| TARS TARSUS PHARMACEUTICALS INC | 2.8% | $18.6m |
| ENGENE HOLDINGS INC | 2.5% | $16.7m |
| ZENAS BIOPHARMA INC | 2.0% | $13.5m |
| TGTX TG THERAPEUTICS INC | 1.8% | $11.9m |
| CNC CENTENE CORP DEL | 1.6% | $10.8m |
| CMPX COMPASS THERAPEUTICS INC | 1.5% | $10.4m |
| RVMD REVOLUTION MEDICINES INC | 1.2% | $8.3m |
| GRAL GRAIL INC | 1.1% | $7.4m |
| DNLI DENALI THERAPEUTICS INC | 0.8% | $5.7m |
| HROW HARROW INC | 0.8% | $5.5m |
| RVTY REVVITY INC | 0.6% | $4.2m |
| CELC CELCUITY INC | 0.5% | $3.3m |
| PRAX PRAXIS PRECISION MEDICINES I | 0.5% | $3.2m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 86.2% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Braidwell LP's portfolio?
Across every quarter Braidwell LP has filed, its median largest position is 5.2% of the book and its median top-ten weight is 31.8%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 25.0 completed holding spells, the median lasted 1.0 quarters; 85.0 positions are still open and their final length is unknown.